Why is Teva Pharmaceutical Industries Ltd. ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 11.59%
- Poor long term growth as Net Sales has grown by an annual rate of 0.64% and Operating profit at 4.46% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Teva Pharmaceutical Industries Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Teva Pharmaceutical Industries Ltd.
47.66%
33.55
37.42%
Israel TA-100
48.91%
3.08
16.78%
Quality key factors
Factor
Value
Sales Growth (5y)
0.64%
EBIT Growth (5y)
4.46%
EBIT to Interest (avg)
3.23
Debt to EBITDA (avg)
4.44
Net Debt to Equity (avg)
2.39
Sales to Capital Employed (avg)
0.65
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
11.59%
ROE (avg)
25.11%
Valuation Key Factors 
Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
3.20
EV to EBIT
9.72
EV to EBITDA
7.52
EV to Capital Employed
1.68
EV to Sales
2.05
PEG Ratio
0.47
Dividend Yield
NA
ROCE (Latest)
17.33%
ROE (Latest)
38.03%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish






